Abridge | Competitive Intelligence Insights - May 09, 2025

Dayton Children's Hospital's CIO J.D. Whitlock and CMIO Dr. Abiodun Omoloja discussed how Abridge integrates seamlessly into their workflows, enhancing clinician efficiency and care quality...


Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡


Abridge

🌎 abridge.com

Abridge is a healthcare technology company founded in 2018 that specializes in transforming patient-clinician conversations into structured clinical notes using generative AI. Their platform enhances clinical documentation efficiency, allowing clinicians to focus on patient care while ensuring accurate and auditable AI-generated summaries. Abridge integrates deeply with electronic medical records (EMR) systems, setting industry standards for the responsible use of AI in healthcare.


Abridge - Latest News and Updates

  • Dayton Children's Hospital's CIO J.D. Whitlock and CMIO Dr. Abiodun Omoloja discussed how Abridge integrates seamlessly into their workflows, enhancing clinician efficiency and care quality.
  • TIME named Shivdev Rao, founder of Abridge, to the TIME100 Health list for his leadership in using AI to shape the future of health.
  • Abridge AI, Inc. won the 'AI Tech Sprint for Documenting VA Clinical Encounters and Integrating Community Care Data' challenge and will receive a firm fixed priced contract from the Veterans Health Administration.
  • John Burbridge has joined Abridge as Foundations Engineering Manager in the United States, previously holding a position at another company.
  • Abridge shared insights from a conversation with Dayton Children's Hospital's CIO J.D. Whitlock and CMIO Dr. Abiodun Omoloja.

Sign up to receive regular updates


If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.